By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lannett Company, Inc. 

9000 State Road

Philadelphia  Pennsylvania  19136  U.S.A.
Phone: 800-325-9994 Fax: 215-333-9004



Company News
Lannett (LCI) Announces Approval For Lopinavir And Ritonavir Oral Solution USP, 80 Mg/20 Mg Per mL 1/4/2017 6:16:51 AM
Lannett (LCI) Announces Supplemental Approval For Morphine Sulfate Oral Solution CII, 20 Mg/Ml 12/19/2016 9:52:08 AM
Lannett (LCI) Provides Update On Methylphenidate ER Tablets 11/30/2016 9:44:50 AM
Lannett (LCI) Announces Approval For Metaxalone Tablets USP, 800 Mg 11/28/2016 6:15:39 AM
Lannett (LCI) Announces Approval For Memantine Hydrochloride Tablets USP, 5 mg And 10 mg 11/14/2016 6:38:27 AM
Lannett (LCI) Reports Fiscal 2017 First-Quarter Financial Results 11/4/2016 8:50:31 AM
Lannett (LCI) To Report Fiscal 2017 First-Quarter Financial Results, Host Conference Call On Thursday, November 3 10/27/2016 10:13:37 AM
Lannett (LCI) Announces Successful Phase III Clinical Trial Results For Proprietary C-Topical Product 10/27/2016 6:43:30 AM
Lannett (LCI) Comments On FDA Proposal Regarding Methylphenidate Extended Release Tablets 10/19/2016 8:15:15 AM
Lannett (LCI) Announces Resignation Of Mahendra Dedhiya, Ph.D., Chief Of Scientific Affairs 9/22/2016 8:04:53 AM